Global Flu Vaccination market growth is projected to reach  US$ 9074 million in 2025 to US$ 12510 million in 2031; it is expected to grow at a CAGR of 5.5% from 2025 to 2031.

Global Flu Vaccination Market Trends and Analysis 2025-31

The global Flu Vaccination market size is predicted to grow from US$ 9074 million in 2025 to US$ 12510 million in 2031; it is expected to grow at a CAGR of 5.5% from 2025 to 2031. Influenza vaccines, also known as flu shots, are vaccines that protect against influenza. A new version of the vaccine is developed twice a year as the influenza virus rapidly changes. Most provide modest to high protection against influenza; however, each year this varies. Evidence in adults over 65 years old is poor. They decrease the number of missed days of work by a half day on average. Vaccinating children may protect those around them. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs. Infinity Market Research newest research report, the Flu Vaccination Industry Forecast looks at past sales and reviews total world Flu Vaccination sales in 2024, providing a comprehensive analysis by region and market sector of projected Flu Vaccination sales for 2025 through 2031. With Flu Vaccination sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Flu Vaccination industry. This Insight Report provides a comprehensive analysis of the global Flu Vaccination landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Flu Vaccination portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms unique position in an accelerating global Flu Vaccination market. This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Flu Vaccination and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Flu Vaccination. This report presents a comprehensive overview, market shares, and growth opportunities of Flu Vaccination market by product type, application, key manufacturers and key regions and countries. Segmentation by Type: &nbsp;&nbsp;&nbsp; Trivalent Influenza Vaccine &nbsp;&nbsp;&nbsp; Quadrivalent Influenza Vaccine Segmentation by Application: &nbsp;&nbsp;&nbsp; 6 Months to 3 Years &nbsp;&nbsp;&nbsp; Above 3 Years This report also splits the market by region: &nbsp;&nbsp;&nbsp; Americas &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; United States &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Canada &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Mexico &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Brazil &nbsp;&nbsp;&nbsp; APAC &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; China &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Japan &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Korea &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Southeast Asia &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; India &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Australia &nbsp;&nbsp;&nbsp; Europe &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Germany &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; France &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; UK &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Italy &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Russia &nbsp;&nbsp;&nbsp; Middle East & Africa &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Egypt &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; South Africa &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Israel &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Turkey &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; GCC Countries The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the companys coverage, product portfolio, its market penetration. &nbsp;&nbsp;&nbsp; Sanofi &nbsp;&nbsp;&nbsp; CSL &nbsp;&nbsp;&nbsp; GSK &nbsp;&nbsp;&nbsp; Viatris &nbsp;&nbsp;&nbsp; AstraZeneca &nbsp;&nbsp;&nbsp; Hualan Bio &nbsp;&nbsp;&nbsp; Changchun Institute of Biological &nbsp;&nbsp;&nbsp; Sinovac &nbsp;&nbsp;&nbsp; BCHT &nbsp;&nbsp;&nbsp; Jiangsu GDK &nbsp;&nbsp;&nbsp; KM Biologics Key Questions Addressed in this Report What is the 10-year outlook for the global Flu Vaccination market? What factors are driving Flu Vaccination market growth, globally and by region? Which technologies are poised for the fastest growth by market and region? How do Flu Vaccination market opportunities vary by end market size? How does Flu Vaccination break out by Type, by Application?

1 Scope of the Report &nbsp;1.1 Market Introduction &nbsp;1.2 Years Considered &nbsp;1.3 Research Objectives &nbsp;1.4 Market Research Methodology &nbsp;1.5 Research Process and Data Source &nbsp;1.6 Economic Indicators &nbsp;1.7 Currency Considered &nbsp;1.8 Market Estimation Caveats 2 Executive Summary &nbsp;2.1 World Market Overview &nbsp;2.1.1 Global Flu Vaccination Annual Sales 2020-2031 &nbsp;2.1.2 World Current & Future Analysis for Flu Vaccination by Geographic Region, 2020, 2024 & 2031 &nbsp;2.1.3 World Current & Future Analysis for Flu Vaccination by Country/Region, 2020, 2024 & 2031 &nbsp;2.2 Flu Vaccination Segment by Type &nbsp;2.2.1 Trivalent Influenza Vaccine &nbsp;2.2.2 Quadrivalent Influenza Vaccine &nbsp;2.3 Flu Vaccination Sales by Type &nbsp;2.3.1 Global Flu Vaccination Sales Market Share by Type (2020-2025) &nbsp;2.3.2 Global Flu Vaccination Revenue and Market Share by Type (2020-2025) &nbsp;2.3.3 Global Flu Vaccination Sale Price by Type (2020-2025) &nbsp;2.4 Flu Vaccination Segment by Application &nbsp;2.4.1 6 Months to 3 Years &nbsp;2.4.2 Above 3 Years &nbsp;2.5 Flu Vaccination Sales by Application &nbsp;2.5.1 Global Flu Vaccination Sale Market Share by Application (2020-2025) &nbsp;2.5.2 Global Flu Vaccination Revenue and Market Share by Application (2020-2025) &nbsp;2.5.3 Global Flu Vaccination Sale Price by Application (2020-2025) 3 Global by Company &nbsp;3.1 Global Flu Vaccination Breakdown Data by Company &nbsp;3.1.1 Global Flu Vaccination Annual Sales by Company (2020-2025) &nbsp;3.1.2 Global Flu Vaccination Sales Market Share by Company (2020-2025) &nbsp;3.2 Global Flu Vaccination Annual Revenue by Company (2020-2025) &nbsp;3.2.1 Global Flu Vaccination Revenue by Company (2020-2025) &nbsp;3.2.2 Global Flu Vaccination Revenue Market Share by Company (2020-2025) &nbsp;3.3 Global Flu Vaccination Sale Price by Company &nbsp;3.4 Key Manufacturers Flu Vaccination Producing Area Distribution, Sales Area, Product Type &nbsp;3.4.1 Key Manufacturers Flu Vaccination Product Location Distribution &nbsp;3.4.2 Players Flu Vaccination Products Offered &nbsp;3.5 Market Concentration Rate Analysis &nbsp;3.5.1 Competition Landscape Analysis &nbsp;3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025) &nbsp;3.6 New Products and Potential Entrants &nbsp;3.7 Market M&A Activity & Strategy 4 World Historic Review for Flu Vaccination by Geographic Region &nbsp;4.1 World Historic Flu Vaccination Market Size by Geographic Region (2020-2025) &nbsp;4.1.1 Global Flu Vaccination Annual Sales by Geographic Region (2020-2025) &nbsp;4.1.2 Global Flu Vaccination Annual Revenue by Geographic Region (2020-2025) &nbsp;4.2 World Historic Flu Vaccination Market Size by Country/Region (2020-2025) &nbsp;4.2.1 Global Flu Vaccination Annual Sales by Country/Region (2020-2025) &nbsp;4.2.2 Global Flu Vaccination Annual Revenue by Country/Region (2020-2025) &nbsp;4.3 Americas Flu Vaccination Sales Growth &nbsp;4.4 APAC Flu Vaccination Sales Growth &nbsp;4.5 Europe Flu Vaccination Sales Growth &nbsp;4.6 Middle East & Africa Flu Vaccination Sales Growth 5 Americas &nbsp;5.1 Americas Flu Vaccination Sales by Country &nbsp;5.1.1 Americas Flu Vaccination Sales by Country (2020-2025) &nbsp;5.1.2 Americas Flu Vaccination Revenue by Country (2020-2025) &nbsp;5.2 Americas Flu Vaccination Sales by Type (2020-2025) &nbsp;5.3 Americas Flu Vaccination Sales by Application (2020-2025) &nbsp;5.4 United States &nbsp;5.5 Canada &nbsp;5.6 Mexico &nbsp;5.7 Brazil 6 APAC &nbsp;6.1 APAC Flu Vaccination Sales by Region &nbsp;6.1.1 APAC Flu Vaccination Sales by Region (2020-2025) &nbsp;6.1.2 APAC Flu Vaccination Revenue by Region (2020-2025) &nbsp;6.2 APAC Flu Vaccination Sales by Type (2020-2025) &nbsp;6.3 APAC Flu Vaccination Sales by Application (2020-2025) &nbsp;6.4 China &nbsp;6.5 Japan &nbsp;6.6 South Korea &nbsp;6.7 Southeast Asia &nbsp;6.8 India &nbsp;6.9 Australia &nbsp;6.10 China Taiwan 7 Europe &nbsp;7.1 Europe Flu Vaccination by Country &nbsp;7.1.1 Europe Flu Vaccination Sales by Country (2020-2025) &nbsp;7.1.2 Europe Flu Vaccination Revenue by Country (2020-2025) &nbsp;7.2 Europe Flu Vaccination Sales by Type (2020-2025) &nbsp;7.3 Europe Flu Vaccination Sales by Application (2020-2025) &nbsp;7.4 Germany &nbsp;7.5 France &nbsp;7.6 UK &nbsp;7.7 Italy &nbsp;7.8 Russia 8 Middle East & Africa &nbsp;8.1 Middle East & Africa Flu Vaccination by Country &nbsp;8.1.1 Middle East & Africa Flu Vaccination Sales by Country (2020-2025) &nbsp;8.1.2 Middle East & Africa Flu Vaccination Revenue by Country (2020-2025) &nbsp;8.2 Middle East & Africa Flu Vaccination Sales by Type (2020-2025) &nbsp;8.3 Middle East & Africa Flu Vaccination Sales by Application (2020-2025) &nbsp;8.4 Egypt &nbsp;8.5 South Africa &nbsp;8.6 Israel &nbsp;8.7 Turkey &nbsp;8.8 GCC Countries 9 Market Drivers, Challenges and Trends &nbsp;9.1 Market Drivers & Growth Opportunities &nbsp;9.2 Market Challenges & Risks &nbsp;9.3 Industry Trends 10 Manufacturing Cost Structure Analysis &nbsp;10.1 Raw Material and Suppliers &nbsp;10.2 Manufacturing Cost Structure Analysis of Flu Vaccination &nbsp;10.3 Manufacturing Process Analysis of Flu Vaccination &nbsp;10.4 Industry Chain Structure of Flu Vaccination 11 Marketing, Distributors and Customer &nbsp;11.1 Sales Channel &nbsp;11.1.1 Direct Channels &nbsp;11.1.2 Indirect Channels &nbsp;11.2 Flu Vaccination Distributors &nbsp;11.3 Flu Vaccination Customer 12 World Forecast Review for Flu Vaccination by Geographic Region &nbsp;12.1 Global Flu Vaccination Market Size Forecast by Region &nbsp;12.1.1 Global Flu Vaccination Forecast by Region (2026-2031) &nbsp;12.1.2 Global Flu Vaccination Annual Revenue Forecast by Region (2026-2031) &nbsp;12.2 Americas Forecast by Country (2026-2031) &nbsp;12.3 APAC Forecast by Region (2026-2031) &nbsp;12.4 Europe Forecast by Country (2026-2031) &nbsp;12.5 Middle East & Africa Forecast by Country (2026-2031) &nbsp;12.6 Global Flu Vaccination Forecast by Type (2026-2031) &nbsp;12.7 Global Flu Vaccination Forecast by Application (2026-2031) 13 Key Players Analysis &nbsp;13.1 Sanofi &nbsp;13.1.1 Sanofi Company Information &nbsp;13.1.2 Sanofi Flu Vaccination Product Portfolios and Specifications &nbsp;13.1.3 Sanofi Flu Vaccination Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.1.4 Sanofi Main Business Overview &nbsp;13.1.5 Sanofi Latest Developments &nbsp;13.2 CSL &nbsp;13.2.1 CSL Company Information &nbsp;13.2.2 CSL Flu Vaccination Product Portfolios and Specifications &nbsp;13.2.3 CSL Flu Vaccination Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.2.4 CSL Main Business Overview &nbsp;13.2.5 CSL Latest Developments &nbsp;13.3 GSK &nbsp;13.3.1 GSK Company Information &nbsp;13.3.2 GSK Flu Vaccination Product Portfolios and Specifications &nbsp;13.3.3 GSK Flu Vaccination Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.3.4 GSK Main Business Overview &nbsp;13.3.5 GSK Latest Developments &nbsp;13.4 Viatris &nbsp;13.4.1 Viatris Company Information &nbsp;13.4.2 Viatris Flu Vaccination Product Portfolios and Specifications &nbsp;13.4.3 Viatris Flu Vaccination Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.4.4 Viatris Main Business Overview &nbsp;13.4.5 Viatris Latest Developments &nbsp;13.5 AstraZeneca &nbsp;13.5.1 AstraZeneca Company Information &nbsp;13.5.2 AstraZeneca Flu Vaccination Product Portfolios and Specifications &nbsp;13.5.3 AstraZeneca Flu Vaccination Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.5.4 AstraZeneca Main Business Overview &nbsp;13.5.5 AstraZeneca Latest Developments &nbsp;13.6 Hualan Bio &nbsp;13.6.1 Hualan Bio Company Information &nbsp;13.6.2 Hualan Bio Flu Vaccination Product Portfolios and Specifications &nbsp;13.6.3 Hualan Bio Flu Vaccination Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.6.4 Hualan Bio Main Business Overview &nbsp;13.6.5 Hualan Bio Latest Developments &nbsp;13.7 Changchun Institute of Biological &nbsp;13.7.1 Changchun Institute of Biological Company Information &nbsp;13.7.2 Changchun Institute of Biological Flu Vaccination Product Portfolios and Specifications &nbsp;13.7.3 Changchun Institute of Biological Flu Vaccination Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.7.4 Changchun Institute of Biological Main Business Overview &nbsp;13.7.5 Changchun Institute of Biological Latest Developments &nbsp;13.8 Sinovac &nbsp;13.8.1 Sinovac Company Information &nbsp;13.8.2 Sinovac Flu Vaccination Product Portfolios and Specifications &nbsp;13.8.3 Sinovac Flu Vaccination Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.8.4 Sinovac Main Business Overview &nbsp;13.8.5 Sinovac Latest Developments &nbsp;13.9 BCHT &nbsp;13.9.1 BCHT Company Information &nbsp;13.9.2 BCHT Flu Vaccination Product Portfolios and Specifications &nbsp;13.9.3 BCHT Flu Vaccination Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.9.4 BCHT Main Business Overview &nbsp;13.9.5 BCHT Latest Developments &nbsp;13.10 Jiangsu GDK &nbsp;13.10.1 Jiangsu GDK Company Information &nbsp;13.10.2 Jiangsu GDK Flu Vaccination Product Portfolios and Specifications &nbsp;13.10.3 Jiangsu GDK Flu Vaccination Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.10.4 Jiangsu GDK Main Business Overview &nbsp;13.10.5 Jiangsu GDK Latest Developments &nbsp;13.11 KM Biologics &nbsp;13.11.1 KM Biologics Company Information &nbsp;13.11.2 KM Biologics Flu Vaccination Product Portfolios and Specifications &nbsp;13.11.3 KM Biologics Flu Vaccination Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.11.4 KM Biologics Main Business Overview &nbsp;13.11.5 KM Biologics Latest Developments 14 Research Findings and Conclusion

Report	Global Flu Vaccination Market Growth 2025-2031
Selected License	Single ID:LPI13675

Buyer Information

Order Summary